290 related articles for article (PubMed ID: 30466772)
21. Diagnostic challenge in a series of eleven patients with hyper IgE syndromes.
Yaakoubi R; Mekki N; Ben-Mustapha I; Ben-Khemis L; Bouaziz A; Ben Fraj I; Ammar J; Hamzaoui A; Turki H; Boussofara L; Denguezli M; Haddad S; Ouederni M; Bejaoui M; Chan KW; Lau YL; Mellouli F; Barbouche MR; Ben-Ali M
Front Immunol; 2022; 13():1057679. PubMed ID: 36703986
[TBL] [Abstract][Full Text] [Related]
22. [Severe atopy and allergy--rare hyper-IgE syndrome caused by the DOCK8 mutation as underlying condition].
Koskenvuo M; Kainulainen L; Vanto T; Lukkarinen H; Lähteenmäki P; Ruuskanen O
Duodecim; 2015; 131(6):541-4. PubMed ID: 26237897
[TBL] [Abstract][Full Text] [Related]
23. Multiplexed detection of DOCK8, PGM3 and STAT3 proteins for the diagnosis of Hyper-Immunoglobulin E syndrome using gold nanoparticles-based immunosensor array platform.
Eissa S; Abdulkarim H; Dasouki M; Al Mousa H; Arnout R; Al Saud B; Rahman AA; Zourob M
Biosens Bioelectron; 2018 Oct; 117():613-619. PubMed ID: 30005381
[TBL] [Abstract][Full Text] [Related]
24. Cutaneous manifestations of DOCK8 deficiency syndrome.
Chu EY; Freeman AF; Jing H; Cowen EW; Davis J; Su HC; Holland SM; Turner ML
Arch Dermatol; 2012 Jan; 148(1):79-84. PubMed ID: 21931011
[TBL] [Abstract][Full Text] [Related]
25. Autosomal dominant hyper-IgE syndrome: When hematopoietic stem cell transplantation should be considered?
Oikonomopoulou C; Goussetis E
Pediatr Transplant; 2020 Aug; 24(5):e13699. PubMed ID: 32497403
[TBL] [Abstract][Full Text] [Related]
26. The clinical and laboratory spectrum of dedicator of cytokinesis 8 immunodeficiency syndrome in patients with a unique mutation.
Broides A; Mandola AB; Levy J; Yerushalmi B; Pinsk V; Eldan M; Shubinsky G; Hadad N; Levy R; Nahum A; Ben-Harosh M; Lev A; Simon A; Somech R
Immunol Res; 2017 Jun; 65(3):651-657. PubMed ID: 28070732
[TBL] [Abstract][Full Text] [Related]
27. Hyper-IgE in the allergy clinic--when is it primary immunodeficiency?
Ponsford MJ; Klocperk A; Pulvirenti F; Dalm VASH; Milota T; Cinetto F; Chovancova Z; Rial MJ; Sediva A; Litzman J; Agostini C; van Hagen M; Quinti I; Jolles S
Allergy; 2018 Nov; 73(11):2122-2136. PubMed ID: 30043993
[TBL] [Abstract][Full Text] [Related]
28. [Hyper-IgE syndromes].
He YY; Liu B; Xiao XP
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Jun; 31(11):892-896. PubMed ID: 29775011
[TBL] [Abstract][Full Text] [Related]
29. The hyper-IgE syndromes.
Freeman AF; Holland SM
Immunol Allergy Clin North Am; 2008 May; 28(2):277-91, viii. PubMed ID: 18424333
[TBL] [Abstract][Full Text] [Related]
30. Profound differences in IgE and IgG recognition of micro-arrayed allergens in hyper-IgE syndromes.
Garib V; Ben-Ali M; Kundi M; Curin M; Yaakoubi R; Ben-Mustapha I; Mekki N; Froeschl R; Perkmann T; Valenta R; Barbouche MR
Allergy; 2022 Jun; 77(6):1761-1771. PubMed ID: 34653276
[TBL] [Abstract][Full Text] [Related]
31.
Park B; Liu GY
Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33271763
[TBL] [Abstract][Full Text] [Related]
32. [Hyper IgE syndrome. Opportune diagnosis and management].
Orozco CV; Velásquez LH; Méndez NH; Augusto B; Salazar T
Rev Alerg Mex; 2008; 55(1):38-45. PubMed ID: 18697452
[TBL] [Abstract][Full Text] [Related]
33. [Hyper-IgE syndrome. Lessons from function and defects of STAT-3 or DOCK-8].
Alcántara-Montiel JC; Vega-Torres BI
Rev Alerg Mex; 2016; 63(4):385-396. PubMed ID: 27795219
[TBL] [Abstract][Full Text] [Related]
34. Atopic dermatitis, STAT3- and DOCK8-hyper-IgE syndromes differ in IgE-based sensitization pattern.
Boos AC; Hagl B; Schlesinger A; Halm BE; Ballenberger N; Pinarci M; Heinz V; Kreilinger D; Spielberger BD; Schimke-Marques LF; Sawalle-Belohradsky J; Belohradsky BH; Przybilla B; Schaub B; Wollenberg A; Renner ED
Allergy; 2014 Jul; 69(7):943-53. PubMed ID: 24898675
[TBL] [Abstract][Full Text] [Related]
35. Clinical manifestations, etiology, and pathogenesis of the hyper-IgE syndromes.
Freeman AF; Holland SM
Pediatr Res; 2009 May; 65(5 Pt 2):32R-37R. PubMed ID: 19190525
[TBL] [Abstract][Full Text] [Related]
36. Hyper IgE syndrome: an update on clinical aspects and the role of signal transducer and activator of transcription 3.
Paulson ML; Freeman AF; Holland SM
Curr Opin Allergy Clin Immunol; 2008 Dec; 8(6):527-33. PubMed ID: 18978467
[TBL] [Abstract][Full Text] [Related]
37. Autosomal recessive hyper-IgE syndrome successfully treated with hematopoietic stem cell transplantation.
Lopes J; Teixeira D; Sousa C; Baptista A; Moreira D; Ferreira EO
Pediatr Dermatol; 2019 Sep; 36(5):693-696. PubMed ID: 31338855
[TBL] [Abstract][Full Text] [Related]
38. The first cohort of Iranian patients with hyper immunoglobulin E syndrome: A long-term follow-up and genetic analysis.
Tavassoli M; Abolhassani H; Yazdani R; Ghadami M; Azizi G; Abdolrahim Poor Heravi S; Moeini Shad T; Kokabee M; Movahedi M; Abdshahzadeh H; Gharagozlou M; Rezaei N; Esmaeilzadeh H; Aleyasin S; Aghamohammadi A
Pediatr Allergy Immunol; 2019 Jun; 30(4):469-478. PubMed ID: 30801830
[TBL] [Abstract][Full Text] [Related]
39. STAT3 Hyper-IgE Syndrome-an Update and Unanswered Questions.
Tsilifis C; Freeman AF; Gennery AR
J Clin Immunol; 2021 Jul; 41(5):864-880. PubMed ID: 33932191
[TBL] [Abstract][Full Text] [Related]
40. Hyper IgE syndromes: A clinical approach.
Gharehzadehshirazi A; Amini A; Rezaei N
Clin Immunol; 2022 Apr; 237():108988. PubMed ID: 35351598
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
